Your body recycling itself -- captured on film

Discovery shows how cells decide what to recycle, unlocking debilitating disease's secret

2010-09-13

(Press-News.org) VIDEO: This video shows UBR-box recognition of an arginine residue at the beginning of a protein (blue) targeted for degradation. The structural integrity of the UBR box depends on zinc (grey)...
Click here for more information.

Our bodies recycle proteins, the fundamental building blocks that enable cell growth and development. Proteins are made up of a chain of amino acids, and scientists have known since the 1980s that first one in the chain determines the lifetime of a protein. McGill researchers have finally discovered how the cell identifies this first amino acid – and caught it on camera.

"There are lots of reasons cells recycle proteins – fasting, which causes loss of muscle, growth and remodeling during development, and normal turnover as old proteins are replaced to make new ones," explained lead researcher, Dr. Kalle Gehring, from McGill's Department of Biochemistry. "One way that cells decide which proteins to degrade is the presence of a signal known as an N-degron at the start of the protein. By X-ray crystallography, we discovered that the N-degron is recognized by the UBR box, a component of the cells' recycling system." The powerful technique can pinpoint the exact location of atoms and enabled the team to capture an image of the UBR box, providing insight to this incredibly tiny yet essential part of our bodies' chemical mechanics.

Aside from representing a major advance in our understanding of the life cycle of proteins, the research has important repercussions for Johanson-Blizzard syndrome, a rare disease that causes deformations and mental retardation. This syndrome is caused by a mutation in the UBR box that causes it to lose an essential zinc atom. Better understanding of the structure of the UBR box may help researchers develop treatments for this syndrome.

INFORMATION:

The research was published in Nature Structural & Molecular Biology and received funding from the Canadian Institutes of Health Research.

For more information: Department of Biochemistry, McGill University
http://www.mcgill.ca/biochemistry/

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

How football playing robots have the future of artificial intelligence at their feet

2010-09-13

The new Premier League season has begun and in Madrid the World Cup celebrations are barely over, yet according to research in WIREs Cognitive Science the world's best players may soon be facing a new challenge from football playing robots, which their creators claim will be able to play and beat a human team. The research reveals how building robots to play football is driving the development of artificial intelligence and robotic technology which can be used for roles including search and rescue and home help. The author, Claude Sammut, from the ARC Centre of Excellence ...

Breakthrough in drug trial offers hope for heart attack patients

2010-09-13

New findings from a major drug trial have brought experts a step closer to developing a drug which could prevent thousands of British deaths from heart attacks. Dr Robert Storey, Reader at the University of Sheffield and Consultant Cardiologist at Sheffield Teaching Hospitals, was the UK lead for international trials of a new drug, ticagrelor, which have been taking place over the last six years. The new findings from one of these studies, the ONSET/OFFSET study, revealed that the platelet function in patients taking ticagrelor recovered much quicker after the drug ...

Brain stimulation can help partially paralyzed stroke patients regain use of their muscles

2010-09-13

Stroke patients who were left partially paralysed found that their condition improved after they received a simple and non-invasive method of brain stimulation, according to research in the September issue of the European Journal of Neurology. Researchers from the Ain Shams University in Cairo, Egypt, studied 60 patients with ischaemic stroke - where the blood supply is reduced to the brain - who had been left with mild to moderate muscle weakness down one side of their body. Twenty of the randomly assigned treatment group received repetitive transcranial magnetic ...

MIT researchers develop a way to funnel solar energy

2010-09-13

CAMBRIDGE, Mass. - Using carbon nanotubes (hollow tubes of carbon atoms), MIT chemical engineers have found a way to concentrate solar energy 100 times more than a regular photovoltaic cell. Such nanotubes could form antennas that capture and focus light energy, potentially allowing much smaller and more powerful solar arrays. "Instead of having your whole roof be a photovoltaic cell, you could have little spots that were tiny photovoltaic cells, with antennas that would drive photons into them," says Michael Strano, the Charles and Hilda Roddey Associate Professor of ...

Engineers make artificial skin out of nanowires

2010-09-13

Berkeley – Engineers at the University of California, Berkeley, have developed a pressure-sensitive electronic material from semiconductor nanowires that could one day give new meaning to the term "thin-skinned." "The idea is to have a material that functions like the human skin, which means incorporating the ability to feel and touch objects," said Ali Javey, associate professor of electrical engineering and computer sciences and head of the UC Berkeley research team developing the artificial skin. The artificial skin, dubbed "e-skin" by the UC Berkeley researchers, ...

Cancer deaths fall, but prevention still lags behind

2010-09-13

Although overall mortality from cancer is decreasing in the European Union, its incidence increased by almost 20%, from 2.1 million new cases in 2002 to 2.5 million in 2008, says a special issue [1] of the European Journal of Cancer (the official journal of ECCO – the European CanCer Organisation) on cancer prevention, published today (Monday 13 September). The current economic crisis threatens to affect cancer incidence in a number of areas, says a paper by Dr. José M. Martin-Moreno from the University of Valencia, Spain, and colleagues. Public donations to cancer ...

Scripps Research scientists solve long-standing mystery of protein 'quality control' mechanism

2010-09-13

LA JOLLA, CA – September 9, 2010 – Scientists from The Scripps Research Institute have solved a long-standing mystery of how cells conduct "quality control" to eliminate the toxic effects of a certain kind of error in protein production. The findings may lead to a better understanding of a host of neurodegenerative diseases. The research was published in an advance, online issue of the journal Nature on September 12, 2010. "It is exciting because we are dealing not only with a process that is clearly relevant for physiology and disease," said Scripps Research Assistant ...

Gene discovery could yield treatments for nearsightedness

2010-09-13

DURHAM, N.C. -- Myopia (nearsightedness) is the most common eye disorder in the world and becoming more common, yet little is known about its genetic underpinnings. Scientists at Duke University Medical Center, in conjunction with several other groups, have uncovered a gene associated with myopia in Caucasian people from several different regions, including Dutch, British and Australian subjects. Their work was published in Nature Genetics online on Sunday, Sept. 12. Myopia happens when the focal point of an image falls just short of the retina at the rear of the ...

Henry Ford Hospital study: hVISA linked to high mortality

2010-09-13

A MRSA infection with a reduced susceptibility to the potent antibiotic drug vancomycin is linked to high mortality, according to a Henry Ford Hospital study. Researchers found that patients who contracted a MRSA infection with heteroresistance, called hVISA, stayed in the hospital longer, were more likely to have the infection return after 90 days, and were twice as likely to die from it after 90 days than patients who do not have hVISA. The study is being presented Sunday at the 50th annual Interscience Conference on Antimicrobial Agents and Chemotherapy in Boston. "Based ...

Early prostate cancer detection, screening: No benefit for men with low baseline PSA value

2010-09-13

Men aged 55 to 74 years who have low baseline blood levels of prostate specific antigen (PSA) are not likely to benefit from further screening and treatment. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The aim of the study is to help physicians and patients weigh the pros and cons of prostate cancer screening and early detection. Prostate cancer is the most commonly diagnosed malignancy and the third leading cause of death from cancer in men in Western countries. While a man in the United ...

Your body recycling itself -- captured on film

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: